Table 5

Experimental therapies for myelofibrosis with reported efficacy for symptomatic splenomegaly

AnemiaSplenomegalyConstitutional symptomsPruritusReference
INCB018424 < 10% 43 
CEP-701 < 10% — 47 
XL019 — 46 
TG101348 — 45 
ITF2357 — 48 
AnemiaSplenomegalyConstitutional symptomsPruritusReference
INCB018424 < 10% 43 
CEP-701 < 10% — 47 
XL019 — 46 
TG101348 — 45 
ITF2357 — 48 

— indicates not applicable; and X, instance.

Close Modal

or Create an Account

Close Modal
Close Modal